Janus Living Inc.: Barclays cuts target price to $33 from $34
JAN•Barclays cut its target price for Janus Living Inc. to $33 from $34.
Related News
InMode updates financial calendar, sets third-quarter 2026 results release date
INMD•
Nurix Therapeutics target price cut to $33 from $34 by Truist Securities
NRIX•
Charles Schwab target price cut to $125 from $130 by Truist Securities
SCHW•
IQVIA expands partnership with Veeva, selects its clinical operations apps as enterprise standard
VEEV•
Goldman Sachs cuts Upstart Holdings target price to $28 from $39
UPST•